Robert Friesen
Plus aucun poste en cours
Profil
Robert Friesen worked as the Head of Preclinical & Early Clinical Development at MorphoSys AG from 2005 to 2008.
He then served as the Chief Scientific Officer at Ablynx NV from 2018 to 2019.
Prior to that, he was the Vice President of Biologics Research at Janssen Research & Development LLC from 2014 to 2016.
From 2016 to 2018, he held the position of Senior Vice President at ProQR Therapeutics NV.
In 2019 to 2021, he worked as the Chief Scientific Officer at Kiadis Pharma NV.
Additionally, he held the position of Global Head of Biologics Research at Janssen Biotherapeutics and Chief Scientific Officer at Pharming Group NV.
Dr. Friesen holds a doctorate degree from The University of Texas at Austin and a graduate degree from the University of Utrecht.
Anciens postes connus de Robert Friesen
| Sociétés | Poste | Fin |
|---|---|---|
| KIADIS PHARMA N.V. | Chief Tech/Sci/R&D Officer | 01/08/2021 |
| ABLYNX | Chief Tech/Sci/R&D Officer | 01/01/2019 |
| PROQR THERAPEUTICS N.V. | Corporate Officer/Principal | 01/02/2018 |
Janssen Research & Development LLC
 Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Part of Johnson & Johnson, Janssen Research & Development LLC is a private company that provides research and development medicines and solutions to other medical needs. The company is based in Raritan, NJ. | Corporate Officer/Principal | 01/06/2016 |
| MORPHOSYS AG | Corporate Officer/Principal | 01/07/2008 |
Formation de Robert Friesen
| The University of Texas at Austin | Doctorate Degree |
| University of Utrecht | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| MORPHOSYS AG | Health Technology |
| PHARMING GROUP N.V. | Health Technology |
| PROQR THERAPEUTICS N.V. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Ablynx NV
 Ablynx NV BiotechnologyHealth Technology Ablynx NV operates as a clinical stage biopharmaceutical company, which engages in the development of proprietary therapeutic proteins under the Nanobodies brand. It includes haematology, inflammation, infectious disease, autoimmune disease, oncology and immune-oncology. The company was founded by Mark Vaeck in 2001 and is headquartered in Ghent, Belgium. | Health Technology |
Janssen Research & Development LLC
Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Part of Johnson & Johnson, Janssen Research & Development LLC is a private company that provides research and development medicines and solutions to other medical needs. The company is based in Raritan, NJ. | Commercial Services |
Kiadis Pharma NV
 Kiadis Pharma NV Pharmaceuticals: MajorHealth Technology Kiadis Pharma NV engages in pharmaceutical development of cell-based immunotherapy products in the field of diseases of the blood building system. Its lead product is the ATIR101. The company was founded in 1997 and is headquartered in Amsterdam, the Netherlands. | Health Technology |
| Janssen Biotherapeutics |
